How AI and Decentralized Clinical Trials are Changing Biopharma


“As humans, we have limitations in being able to integrate and synthesize and look at data,” says venture capitalist John Orloff, formerly Global Head of R&D at Alexion Pharmaceuticals. “I think AI and machine learning technology will allow us to make better decisions and choices, and give us new insights into how to approach certain diseases.” More from Orloff inside…


Register For Free Access!

Share a little bit of info to have a look at this article, and get instant access to:

  • Case studies on how innovation happens in the world’s top companies
  • Our on-demand video library with 100+ hours of workshops and exclusive interviews with senior leaders
  • Assessment tests that give you an instant score
  • Curated content on getting an innovation program started


Want to become a member and get full access to everything? Learn more here.

If you are already a registered user or a member you can SIGN IN now.